Nucleic Acids Research Advance Access originally published online on November 29, 2007
Nucleic Acids Research 2008 36(Database issue):D901-D906; doi:10.1093/nar/gkm958
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nucleic Acids Research, 2008, Vol. 36, Database issue D901-D906
© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article appears in the following Nucleic Acids Research issue: Database issue [View the issue table of contents]
Articles |
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Department of Computing Science and Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E8
*To whom correspondence should be addressed. Tel: 780-492-0383; Fax: 780-492-1071; Email: david.wishart{at}ulberta.ca
Received September 15, 2007. Revised October 11, 2007. Accepted October 15, 2007.
DrugBank is a richly annotated resource that combines detailed drug data with comprehensive drug target and drug action information. Since its first release in 2006, DrugBank has been widely used to facilitate in silico drug target discovery, drug design, drug docking or screening, drug metabolism prediction, drug interaction prediction and general pharmaceutical education. The latest version of DrugBank (release 2.0) has been expanded significantly over the previous release. With 
4900 drug entries, it now contains 60% more FDA-approved small molecule and biotech drugs including 10% more ‘experimental’ drugs. Significantly, more protein target data has also been added to the database, with the latest version of DrugBank containing three times as many non-redundant protein or drug target sequences as before (1565 versus 524). Each DrugCard entry now contains more than 100 data fields with half of the information being devoted to drug/chemical data and the other half devoted to pharmacological, pharmacogenomic and molecular biological data. A number of new data fields, including food–drug interactions, drug–drug interactions and experimental ADME data have been added in response to numerous user requests. DrugBank has also significantly improved the power and simplicity of its structure query and text query searches. DrugBank is available at http://www.drugbank.ca
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Yamanishi, M. Araki, A. Gutteridge, W. Honda, and M. Kanehisa Prediction of drug-target interaction networks from the integration of chemical and genomic spaces Bioinformatics, July 1, 2008; 24(13): i232 - i240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Segota, N. Bartonicek, and K. Vlahovicek MADNet: microarray database network web server Nucleic Acids Res., July 1, 2008; 36(suppl_2): W332 - W335. [Abstract] [Full Text] [PDF]
|
|